BioMenace Remastered

Rigel Gameworks · 2025 · $14.99 · Action · deal grade D

• Estimated net residual revenue: $720 to $1.1k per month
• Opportunity: $901 per month at x1.00 dormancy
• Estimated lifetime owners: 5.7k
• 99%% positive across 179 reviews · 7.2 reviews/month

Why it's flagged

• Developer active, last post 0 months ago
• Last build shipped 0 months ago
• Store page localized in only 1 language(s)

This case as Markdown · Estimates carry ±30-50%% error per title.